Full-Time
Evidence-based medical knowledge platform for clinicians
No salary listed
Berlin, Germany
Hybrid
Hybrid role with Berlin base; remote work allowed from other company offices (Cologne, Sardinia, Cape Town).
AMBOSS provides a medical knowledge platform used by students and clinicians. It combines an interactive library and high-yield question bank for students to study and prep for exams with a clinical decision support system for clinicians to guide patient care using evidence-based recommendations. The platform works online: users search and study from the medical library, practice with questions, and access point-of-care guidance and clinical decision support at the bedside or in clinics. AMBOSS differentiates itself through its physician-founded approach, a global team of physicians, scientists, and engineers, and its breadth of content that serves over a million healthcare professionals in 180+ countries, integrating both learning tools and real-time clinical guidance in one platform. The company aims to improve medical knowledge and clinical decision-making worldwide, helping physicians provide better patient care.
Company Size
1,001-5,000
Company Stage
Late Stage VC
Total Funding
$302M
Headquarters
Berlin, Germany
Founded
2012
Help us improve and share your feedback! Did you find this helpful?
People at Amboss who can refer or advise you
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Mental Health Support
Flexible Work Hours
Remote Work Options
Relocation Assistance
STARTUPLAND is set for November 5 at Cologne's RheinEnergieStadion, featuring talks, pitches, and networking. Key speakers include Sievert Weiss of Amboss, which raised €240 million at an €800 million valuation, and Shikha Ahluwalia from Balderton Capital, focusing on mental health. Sven Lackinger of Sastrify will discuss challenges in scaling. The event includes a pitch stage for young startups and is part of the RISE in STARTUPLAND-Week, turning Cologne into a startup hub.
BPI has invested in AMBOSS, a platform evolving from a medical student tool to an AI-supported clinical companion for healthcare professionals. With over 1 million users globally, AMBOSS is expanding in the US and DACH regions. The company operates a hybrid B2C/B2B model, showing strong growth and profitability. AMBOSS is also expanding into new markets and roles, leveraging AI for reliable clinical decision-making. The investment supports AMBOSS's mission to enhance healthcare outcomes.
Amboss, a medical learning platform, is aiming to become a market leader by raising significant funds, more than most healthtech startups. The new capital will also be used for acquisitions, with a key focus on expanding in the USA.
In Q1 2025, over €2.5 billion was invested in more than 40 startups. Notable investments include Finn, Amboss, and Solaris. Finn received up to €1 billion from Citi, Jefferies, and Avellinia Capital. Amboss secured €240 million from Kirkbi, M&G Investments, Lightrock, and existing investors, valuing the company at €800 million. Solaris attracted investment from SBI Group and Boerse Stuttgart Group.
Amboss has raised €240 million in a funding round led by Kirkbi, MG Investments, and Lightrock, with existing investors also participating. The Berlin-based EdTech company is now valued at approximately €800 million. The new capital will be used to expand into international markets and enhance offerings for healthcare professionals.